Right now you are surfing a limited version of umu.se. What does this mean?

"False"
Umeå University
printicon
Main menu hidden.

Börje Ljungberg

Research qualifications: Docent

Contact

E-mail
borje.ljungberg@umu.se
Phone
+46 90 786 72 84

Works as

Affiliation
Professor at Department of Diagnostics and Intervention
Location
5A, Målpunkt H62, Norrlands universitetssjukhus Umeå universitet, 901 85 Umeå
Spectral and stiffness characterization of whole prostate gland to assist superficial cancer detection during radical prostatectomy
Spectrochimica Acta Part A - Molecular and Biomolecular Spectroscopy, Elsevier 2026, Vol. 347
Lindahl, Olof A; Gorzsás, András; Bergh, Anders; et al.
Diagnosis and initial management of renal cell carcinoma
Primer on urology, Cham: Springer 2025 : 273-288
Dabestani, Saeed; Ljungberg, Börje
Non-surgical management vs active treatment in T1a renal cell carcinoma: a population-based study
BJU International
Hashim, Bassam Mazin; Rosenblad, Andreas Karlsson; Lundgren, Per-Olof; et al.
Addressing the need for predictive tools in postoperative abdominal wall complications after nephrectomy: evaluation of a novel abdominal bulge grading system using computed tomography
Acta Radiologica Open, Sage Publications 2025, Vol. 14, (8)
Inkiläinen, Aapo; Ljungberg, Börje; Blomqvist, Lennart; et al.
Healthcare costs in relation to increased use of preoperative renal tumour biopsies
Scandinavian journal of urology, MJS Publishing 2025, Vol. 60 : 66-72
Lind, Agnes; Mazin Hashim, Bassam; Hagman, Matilda; et al.
Liquid biomarkers associate with TGF-β Type I receptor and hypoxia in kidney cancer
Signal Transduction and Targeted Therapy, Springer Nature 2025, Vol. 10, (1)
Mallikarjuna, Pramod; Erdem, Cemal; Ilundain Beorlegui, Ruben; et al.
Hospital volume as a determinant of outcomes after partial nephrectomy: a systematic review by the european association of urology renal cell carcinoma guidelines panel
European Urology Oncology, Elsevier 2025, Vol. 8, (3) : 616-622
Marconi, Lorenzo; Kuusk, Teele; Hora, Milan; et al.
Reply to the letter to the editor about “recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis” by Lundgren and Radros
World journal of urology, Springer Nature 2025, Vol. 43, (1)
Rosenblad, Andreas Karlsson; Hashim, Bassam Mazin; Lindblad, Per; et al.
Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial
BMC Cancer, BioMed Central (BMC) 2024, Vol. 24, (1)
Iisager, Laura; Ahrenfeldt, Johanne; Donskov, Frede; et al.
Reply to Letter to the Editor about "Recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis" by Qiang et al
World journal of urology, Springer Nature 2024, Vol. 42, (1)
Karlsson Rosenblad, Andreas; Hashim, Bassam Mazin; Lindblad, Per; et al.
Multiple factors influence decision making for the surgical treatment in patients with renal cell carcinoma
Scandinavian journal of urology, Medical Journals Sweden 2024, Vol. 59 : 26-30
Kröger Dahlin, Britt-Inger; Hlodan, Jan; Ghaffarpour, Ramin; et al.
Is Partial Nephrectomy A Primary Option for Patients with T1b Renal Cell Carcinoma—A National Population-Based Study
Urology Research and Practice, Aves Yayincilik A.Ş. 2024, Vol. 50, (6) : 322-327
Lundstam, Sven; Almdalal, Tarik; Karlsson Rosenblad, Andreas; et al.
Diagnostic accuracy and safety of renal tumour biopsy in patients with small renal masses and its impact on treatment decisions
Scandinavian journal of urology, Medical Journals Sweden 2024, Vol. 59 : 141-146
Mazin Hashima, Bassam; Chabok, Abbas; Ljungberg, Börje; et al.
Recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis
World journal of urology, Springer Nature 2024, Vol. 42, (1)
Rosenblad, Andreas Karlsson; Hashim, Bassam Mazin; Lindblad, Per; et al.
Expression of HIF‑α and their association with clinicopathological parameters in clinical renal cell carcinoma
Upsala Journal of Medical Sciences, Uppsala Medical Society 2024, Vol. 129
Tumkur Sitaram, Raviprakash; Ljungberg, Börje
End-stage renal disease after renal cancer surgery: risk factors and overall survival
Scandinavian journal of urology, Medical Journals Sweden 2024, Vol. 59 : 109-116
Åkerlund, John; Ljungberg, Börje; Lundstam, Sven; et al.
Predictive characteristics for disease recurrence and overall survival in non-metastatic clinical T1 renal cell carcinoma: results from the National Swedish Kidney Cancer Register
Scandinavian journal of urology, Taylor & Francis Group 2023, Vol. 57, (1-6) : 67-74
Almdalal, Tarik; Karlsson Rosenblad, Andreas; Hellström, Mikael; et al.
The 2022 updated European association of urology guidelines on the use of adjuvant immune checkpoint inhibitor therapy for renal cell carcinoma
European Urology, Elsevier 2023, Vol. 83, (1) : 10-14
Bedke, Jens; Albiges, Laurence; Capitanio, Umberto; et al.
Dietary vitamin D intake and the bladder cancer risk: a pooled analysis of prospective cohort studies
Clinical Nutrition, Elsevier 2023, Vol. 42, (8) : 1462-1474
Boot, Iris W.A.; Wesselius, Anke; Yu, Evan Y.W.; et al.
Reply to Yaxiong Tang, Xu Hu, Kan Wu, Yanxiang Shao, and Xiang Li’s Letter to the Editor re: Umberto Capitanio, Jens Bedke, Laurence Albiges, et al. A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. Eur Urol. 2022;83:3–5
European Urology, Elsevier 2023, Vol. 83, (3) : e74-e75
Capitanio, Umberto; Bedke, Jens; Albiges, Laurence; et al.
A renewal of the tnm staging system for patients with renal cancer to comply with current decision-making: Proposal from the European Association of Urology guidelines panel
European Urology, Elsevier 2023, Vol. 83, (1) : 3-5
Capitanio, Umberto; Bedke, Jens; Albiges, Laurence; et al.
Reproductive and hormonal factors and risk of renal cell carcinoma among women in the european prospective investigation into cancer and nutrition
Cancer Medicine, John Wiley & Sons 2023, Vol. 12, (14) : 15588-15600
Clasen, Joanna L.; Mabunda, Rita; Heath, Alicia K.; et al.
Identification and validation of NFIA as a novel prognostic marker in renal cell carcinoma
The journal of pathology. Clinical research, John Wiley & Sons 2023, Vol. 9, (4) : 261-272
de Alwis, Roger; Schoch, Sarah; Islam, Mazharul; et al.
European association of urology guidelines panel on renal cell carcinoma update on the new world health organization classification of kidney tumours 2022: the urologist's point of view
European Urology, Elsevier 2023, Vol. 83, (2) : 97-100
Hora, Milan; Albiges, Laurence; Bedke, Jens; et al.
Local treatment of recurrent renal cell carcinoma may have a significant survival effect across all risk-of-recurrence groups
European Urology Open Science, Elsevier 2023, Vol. 47 : 65-72
Marconi, Lorenzo; Kuusk, Teele; Capitanio, Umberto; et al.
Predictors for complication in renal cancer surgery: a national register study
Scandinavian journal of urology, Medical Journals Sweden 2023, Vol. 58 : 38-45
Åkerlund, John; Sundqvist, Pernilla; Ljungberg, Börje; et al.
The relationship between blood pressure and risk of renal cell carcinoma
International Journal of Epidemiology, Oxford University Press 2022, Vol. 51, (4) : 1317-1327
Alcala, Karine; Mariosa, Daniela; Smith-Byrne, Karl; et al.
Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease: A National Register Study
European Urology Open Science, Vol. 39 : 22-28
Almadalal, Tarik; Sundqvist, Pernilla; Harmenberg, Ulrika; et al.
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma
European Urology, Elsevier 2022, Vol. 81, (2) : 134-137
Bedke, Jens; Albiges, Laurence; Capitanio, Umberto; et al.
Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry
European Urology Open Science, Elsevier 2022, Vol. 45 : 12-22
Bjartell, Anders; Costa, Luis; Kramer, Gero; et al.
Mycotoxin Exposure and Renal Cell Carcinoma Risk: An Association Study in the EPIC European Cohort
Nutrients, MDPI 2022, Vol. 14, (17)
Claeys, Liesel; De Saeger, Sarah; Scelo, Ghislaine; et al.
Recurrence pattern in localized RCC: results from a European multicenter database (RECUR)
Urologic Oncology, Elsevier 2022, Vol. 40, (11) : 494.e11-494.e17
Fallara, Giuseppe; Larcher, Alessandro; Dabestani, Saeed; et al.
Mild-to-moderate kidney dysfunction and cardiovascular disease: Observational and mendelian randomization analyses
Circulation, Wolters Kluwer 2022, Vol. 146, (20) : 1507-1517
Gaziano, Liam; Sun, Luanluan; Arnold, Matthew; et al.
Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years
PLOS ONE, Public Library of Science 2022, Vol. 17, (1)
Hemminki, Kari; Försti, Asta; Hemminki, Akseli; et al.
Incidence trends in lung and bladder cancers in the Nordic Countries before and after the smoking epidemic
European Journal of Cancer Prevention, Lippincott Williams & Wilkins 2022, Vol. 31, (3) : 228-234
Hemminki, Kari; Försti, Asta; Hemminki, Akseli; et al.
Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma
Scandinavian journal of urology, Taylor & Francis 2022, Vol. 56, (5-6) : 383-390
Karlsson Rosenblad, Andreas; Sundqvist, Pernilla; Harmenberg, Ulrika; et al.
Ilixadencel, a cell-based immune primer, plus sunitinib versus sunitinib alone in metastatic renal cell carcinoma: a randomized phase 2 study
European Urology Open Science, Elsevier 2022, Vol. 40 : 38-45
Lindskog, Magnus; Laurell, Anna; Kjellman, Anders; et al.
Kidney tumor biopsy – an unmet need for personalized treatment
Scandinavian journal of urology, Taylor & Francis 2022, Vol. 56, (5-6) : 373-374
Ljungberg, Börje
European Association of Urology Guidelines on Renal Cell Carcinoma: the 2022 Update
European Urology, Elsevier 2022, Vol. 82, (4) : 399-410
Ljungberg, Börje; Albiges, Laurence; Abu-Ghanem, Yasmin; et al.
Reply to Yongbao Wei, Ruochen Zhang, and Le Lin's Letter to the Editor re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022;82:e88
European Urology, Elsevier 2022, Vol. 82, (4) : e111-e112
Ljungberg, Börje; Bedke, Jens; Capitanio, Umberto; et al.
Inflammatory response markers and survival prediction in patients with renal cell carcinoma
Scandinavian journal of urology, Taylor & Francis Group 2022, Vol. 56, (1) : 47-52
Mountzias, Alexander; Hultdin, Johan; Hlodan, Jan; et al.
Spinal anaesthesia with clonidine: pain relief and earlier mobilisation after open nephrectomy – a randomised clinical trial
Journal of international medical research, Sage Publications 2022, Vol. 50, (9) : 1-12
Thurm, Mascha; Hultin, Magnus; Johansson, Göran; et al.
Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
BJU International, John Wiley & Sons 2021, Vol. 128, (3) : 386-394
Abu-Ghanem, Yasmin; Powles, Thomas; Capitanio, Umberto; et al.
The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery: Results from RECUR Consortium
European Urology Oncology, Elsevier 2021, Vol. 4, (3) : 473-482
Abu-Ghanem, Yasmin; Powles, Thomas; Capitanio, Umberto; et al.
The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor–based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care
European Urology, Elsevier 2021, Vol. 80, (4) : 393-397
Bedke, Jens; Albiges, Laurence; Capitanio, Umberto; et al.
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma
European Urology, Elsevier 2021, Vol. 79, (3) : 339-342
Bedke, Jens; Albiges, Laurence; Capitanio, Umberto; et al.
Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature
European Urology Oncology, Elsevier 2021, Vol. 4, (1) : 22-41
Campi, Riccardo; Stewart, Grant D.; Staehler, Michael; et al.
The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium
PLoS Medicine, Public Library of Science (PLOS) 2021, Vol. 18, (9)
Guida, Florence; Tan, Vanessa Y.; Corbin, Laura J.; et al.
Soft drink and juice consumption and renal cell carcinoma incidence and mortality in the european prospective investigation into cancer and nutrition
Cancer Epidemiology, Biomarkers and Prevention, American Association for Cancer Research 2021, Vol. 30, (6) : 1270-1274
Heath, Alicia K.; Clasen, Joanna L.; Jayanth, Nick P.; et al.
Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden
PLOS ONE, Public Library of Science 2021, Vol. 16
Hemminki, Kari; Försti, Asta; Hemminki, Akseli; et al.
View publications in DiVA